Cargando…
microRNA-145-5p inhibits prostate cancer bone metastatic by modulating the epithelial-mesenchymal transition
OBJECTIVE: To investigate the effects of miRNA-145-5p on the tumor development and progression of prostate cancer (Pca) bone metastasis. METHODS: Levels of miRNA-145-5p were assessed by real-time quantitative PCR in PC3 (bone metastatic Pca cells), 22RV1 (non-metastatic Pca cells), RWPE-1 (non-cance...
Autores principales: | Luo, Bingfeng, Yuan, Yuan, Zhu, Yifei, Liang, Songwu, Dong, Runan, Hou, Jian, Li, Ping, Xing, Yaping, Lu, Zhenquan, Lo, Richard, Kuang, Guan-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486105/ https://www.ncbi.nlm.nih.gov/pubmed/36147907 http://dx.doi.org/10.3389/fonc.2022.988794 |
Ejemplares similares
-
Exosome-Derived miRNAs as Potential Biomarkers for Prostate Bone Metastasis
por: Lu, Zhenquan, et al.
Publicado: (2022) -
MicroRNAs and epithelial-mesenchymal transition in prostate cancer
por: Sekhon, Kirandeep, et al.
Publicado: (2016) -
MicroRNA-145 suppresses epithelial to mesenchymal transition in pancreatic cancer cells by inhibiting TGF-β signaling pathway
por: Chen, Shaojun, et al.
Publicado: (2020) -
MicroRNA-145-5p inhibits gastric cancer invasiveness through targeting N-cadherin and ZEB2 to suppress epithelial–mesenchymal transition
por: Jiang, Shi-Bin, et al.
Publicado: (2016) -
microRNA-802 inhibits epithelial-mesenchymal transition through targeting flotillin-2 in human prostate cancer
por: Wang, Dawei, et al.
Publicado: (2017)